← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Claritev Corporation (CTEV) 10-Year Financial Performance & Capital Metrics

CTEV • • Industrial / General
HealthcareHealthcare ITRevenue Cycle ManagementClaims Processing & Payment Integrity
AboutClaritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.Show more
  • Revenue $931M -3.2%
  • EBITDA -$953M -262.2%
  • Net Income -$1.65B -1694.9%
  • EPS (Diluted) -101.92 -1691.2%
  • Gross Margin 74.27% -1.6%
  • EBITDA Margin -102.46% -267.6%
  • Operating Margin -149.35% -986.6%
  • Net Margin -176.85% -1754.5%
  • ROE -183.57% -3403.0%
  • ROIC -19.28% -1087.4%
  • Debt/Equity 54.05 +1922.3%
  • Interest Coverage -4.26 -976.1%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗High debt to equity ratio of 54.0x
  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 13 (bottom 13%)
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y-1.09%
3Y-5.92%
TTM0.89%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM77.8%

EPS CAGR

10Y-
5Y-
3Y-
TTM78.08%

ROCE

10Y Avg-3.09%
5Y Avg-4.59%
3Y Avg-8.71%
Latest-23.69%

Peer Comparison

Claims Processing & Payment Integrity
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
PINCPremier, Inc.2.34B28.26128.45-10.86%-2.42%-1.59%13.64%0.18
SCNXScienture Holdings, Inc.21.25M0.520.21-89.98%-31.46%-24.86%0.04
MSPRMSP Recovery, Inc.950.43K0.07-0.00136.85%-73.28%-55.86%
CTEVClaritev Corporation496.76M30.06-0.29-3.21%-35.93%-183.57%54.05
TBRGTruBridge, Inc.326.3M21.74-15.750.95%1.59%30.92%3.99%1.04

Profit & Loss

Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+982.9M937.76M1.12B1.08B961.52M930.62M
Revenue Growth %--0.05%0.19%-0.03%-0.11%-0.03%
Cost of Goods Sold+149.61M318.68M175.29M204.1M235.47M239.4M
COGS % of Revenue0.15%0.34%0.16%0.19%0.24%0.26%
Gross Profit+833.29M619.09M942.31M875.62M726.06M691.22M
Gross Margin %0.85%0.66%0.84%0.81%0.76%0.74%
Gross Profit Growth %--0.26%0.52%-0.07%-0.17%-0.05%
Operating Expenses+465.08M750.91M556.19M1.24B564.07M2.08B
OpEx % of Revenue0.47%0.8%0.5%1.15%0.59%2.24%
Selling, General & Admin75.22M355.63M151.09M132.14M135.99M160.22M
SG&A % of Revenue0.08%0.38%0.14%0.12%0.14%0.17%
Research & Development000000
R&D % of Revenue------
Other Operating Expenses389.86M395.27M405.1M1.11B428.08M1.92B
Operating Income+368.21M-131.82M386.12M-362.73M161.98M-1.39B
Operating Margin %0.37%-0.14%0.35%-0.34%0.17%-1.49%
Operating Income Growth %--1.36%3.93%-1.94%1.45%-9.58%
EBITDA+767.66M271.86M798.18M52.93M587.77M-953.49M
EBITDA Margin %0.78%0.29%0.71%0.05%0.61%-1.02%
EBITDA Growth %--0.65%1.94%-0.93%10.11%-2.62%
D&A (Non-Cash Add-back)399.45M403.68M412.06M415.66M425.79M436.44M
EBIT386.86M-211.27M402.93M-257.34M226.15M-1.44B
Net Interest Income+-376.15M-335.35M-267.44M-299.9M-324.98M-323.24M
Interest Income196K288K30K3.5M8.23M3.13M
Interest Expense376.35M335.64M267.48M303.4M333.21M326.37M
Other Income/Expense-357.7M-415.09M-250.67M-198.01M-269.04M-380.78M
Pretax Income+10.51M-546.91M135.45M-560.74M-107.06M-1.77B
Pretax Margin %0.01%-0.58%0.12%-0.52%-0.11%-1.9%
Income Tax+799K-26.34M33.37M12.17M-15.36M-124.88M
Effective Tax Rate %0.92%0.95%0.75%1.02%0.86%0.93%
Net Income+9.71M-520.56M102.08M-572.91M-91.7M-1.65B
Net Margin %0.01%-0.56%0.09%-0.53%-0.1%-1.77%
Net Income Growth %--54.61%1.2%-6.61%0.84%-16.95%
Net Income (Continuing)9.71M-520.56M102.08M-572.91M-91.7M-1.65B
Discontinued Operations000000
Minority Interest000000
EPS (Diluted)+0.35-44.236.40-35.87-5.69-101.92
EPS Growth %--127.37%1.14%-6.6%0.84%-16.91%
EPS (Basic)0.35-44.236.40-35.87-5.69-101.92
Diluted Shares Outstanding27.5M11.77M16.29M15.97M16.13M16.15M
Basic Shares Outstanding27.5M11.77M16.28M15.97M16.13M16.15M
Dividend Payout Ratio------

Balance Sheet

Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+115.61M208.85M319.26M446.74M193.59M175.51M
Cash & Short-Term Investments21.82M126.75M185.33M334.05M71.55M16.85M
Cash Only21.82M126.75M185.33M334.05M71.55M16.85M
Short-Term Investments000000
Accounts Receivable77.07M63.2M99.91M78.91M84.75M111.61M
Days Sales Outstanding28.6224.632.6326.6732.1743.77
Inventory000000
Days Inventory Outstanding------
Other Current Assets195K1.19M4.05M10.19M12.49M19.82M
Total Non-Current Assets+8.24B8.07B7.9B6.92B6.77B4.98B
Property, Plant & Equipment207.99M218.97M243.34M257.07M287.11M308.75M
Fixed Asset Turnover4.73x4.28x4.59x4.20x3.35x3.01x
Goodwill4.14B4.26B4.36B3.71B3.83B2.4B
Intangible Assets3.89B3.58B3.29B2.94B2.63B2.23B
Long-Term Investments0000015M
Other Non-Current Assets8.15M14.23M9.7M21.89M21.78M22.1M
Total Assets+8.36B8.28B8.22B7.37B6.96B5.15B
Asset Turnover0.12x0.11x0.14x0.15x0.14x0.18x
Asset Growth %--0.01%-0.01%-0.1%-0.06%-0.26%
Total Current Liabilities+85.79M112.5M141.91M175.84M166.74M213.79M
Accounts Payable9.56M15.26M13.01M13.29M19.59M86.33M
Days Payables Outstanding23.3417.4827.0823.7830.37131.62
Short-Term Debt0013.25M13.25M13.25M13.25M
Deferred Revenue (Current)000000
Other Current Liabilities26.31M21.84M25.42M34.57M44.72M33.69M
Current Ratio1.35x1.86x2.25x2.54x1.16x0.82x
Quick Ratio1.35x1.86x2.25x2.54x1.16x0.82x
Cash Conversion Cycle------
Total Non-Current Liabilities+6.29B5.61B5.73B5.4B5.09B4.85B
Long-Term Debt5.4B4.58B4.88B4.74B4.53B4.51B
Capital Lease Obligations23.19M27.59M26.73M20.89M17.12M13.86M
Deferred Tax Liabilities869.2M900.63M753.83M639.5M521.71M325.83M
Other Non-Current Liabilities0106.59M74.14M2.47M17.26M3.6M
Total Liabilities6.38B5.73B5.88B5.58B5.26B5.07B
Total Debt+5.43B4.61B4.93B4.78B4.57B4.54B
Net Debt5.41B4.49B4.74B4.45B4.5B4.52B
Debt / Equity2.74x1.80x2.10x2.67x2.67x54.05x
Debt / EBITDA7.07x16.97x6.17x90.36x7.77x-
Net Debt / EBITDA7.04x16.50x5.94x84.05x7.65x-
Interest Coverage0.98x-0.39x1.44x-1.20x0.49x-4.26x
Total Equity+1.99B2.56B2.34B1.79B1.71B84.02M
Equity Growth %-0.29%-0.08%-0.24%-0.05%-0.95%
Book Value per Share72.19217.33143.95112.10105.975.20
Total Shareholders' Equity1.99B2.56B2.34B1.79B1.71B84.02M
Common Stock42K66K67K67K2K2K
Retained Earnings637.56M117M225.11M-347.8M-499.31M-2.15B
Treasury Stock0-89.61M-192.17M-192.17M-128.36M-138.73M
Accumulated OCI0000-11.78M-5.06M
Minority Interest000000

Cash Flow

Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+284.31M377.37M404.69M372.36M171.72M107.62M
Operating CF Margin %0.29%0.4%0.36%0.34%0.18%0.12%
Operating CF Growth %-0.33%0.07%-0.08%-0.54%-0.37%
Net Income9.71M-520.56M102.08M-572.91M-91.7M-1.65B
Depreciation & Amortization399.45M403.68M424.32M415.66M425.79M436.44M
Stock-Based Compensation-14.88M406.05M18.01M0026.64M
Deferred Taxes-111.4M-45.04M0-114.38M-114.06M-198.01M
Other Non-Cash Items-4.92M103.23M-93.04M588.66M-26.4M1.5B
Working Capital Changes6.35M30.01M-46.68M55.34M-21.91M-13.67M
Change in Receivables5.28M14.76M-33.83M21M4.4M-13.2M
Change in Inventory000000
Change in Payables20.78M29.07M00042.22M
Cash from Investing+-66.41M-210.84M-228.38M-104.45M-249.79M-118.12M
Capital Expenditures-66.41M-70.81M-84.59M-89.73M-108.85M-118.12M
CapEx % of Revenue0.07%0.08%0.08%0.08%0.11%0.13%
Acquisitions------
Investments------
Other Investing005.64M000
Cash from Financing+-201.09M-61.6M-114.68M-115.74M-180.99M-41.31M
Debt Issued (Net)------
Equity Issued (Net)------
Dividends Paid000000
Share Repurchases------
Other Financing0-2.16B0-2.46M-465K-2.88M
Net Change in Cash------
Free Cash Flow+217.9M306.56M320.1M282.63M62.87M-10.51M
FCF Margin %0.22%0.33%0.29%0.26%0.07%-0.01%
FCF Growth %-0.41%0.04%-0.12%-0.78%-1.17%
FCF per Share7.9226.0519.6517.693.90-0.65
FCF Conversion (FCF/Net Income)29.28x-0.72x3.96x-0.65x-1.87x-0.07x
Interest Paid363.91M312.35M231.05M00315.25M
Taxes Paid114.57M3.92M00080.09M

Key Ratios

Metric201920202021202220232024
Return on Equity (ROE)0.49%-22.92%4.16%-27.71%-5.24%-183.57%
Return on Invested Capital (ROIC)3.74%-1.37%4.1%-4.08%1.95%-19.28%
Gross Margin84.78%66.02%84.32%81.1%75.51%74.27%
Net Margin0.99%-55.51%9.13%-53.06%-9.54%-176.85%
Debt / Equity2.74x1.80x2.10x2.67x2.67x54.05x
Interest Coverage0.98x-0.39x1.44x-1.20x0.49x-4.26x
FCF Conversion29.28x-0.72x3.96x-0.65x-1.87x-0.07x
Revenue Growth--4.59%19.18%-3.39%-10.95%-3.21%

Frequently Asked Questions

Growth & Financials

Claritev Corporation (CTEV) reported $951.0M in revenue for fiscal year 2024. This represents a 3% decrease from $982.9M in 2019.

Claritev Corporation (CTEV) saw revenue decline by 3.2% over the past year.

Claritev Corporation (CTEV) reported a net loss of $341.7M for fiscal year 2024.

Dividend & Returns

Claritev Corporation (CTEV) has a return on equity (ROE) of -183.6%. Negative ROE indicates the company is unprofitable.

Claritev Corporation (CTEV) had negative free cash flow of $113.1M in fiscal year 2024, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.